Unknown

Dataset Information

0

Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model.


ABSTRACT: Spinocerebellar ataxia type 1 (SCA1) is a polyglutamine (polyQ) repeat neurodegenerative disease in which a primary site of pathogenesis are cerebellar Purkinje cells. In addition to polyQ expansion of ataxin-1 protein (ATXN1), phosphorylation of ATXN1 at the serine 776 residue (ATXN1-pS776) plays a significant role in protein toxicity. Utilizing a biochemical approach, pharmacological agents and cell-based assays, including SCA1 patient iPSC-derived neurons, we examine the role of Protein Kinase A (PKA) as an effector of ATXN1-S776 phosphorylation. We further examine the implications of PKA-mediated phosphorylation at ATXN1-S776 on SCA1 through genetic manipulation of the PKA catalytic subunit C? in Pcp2-ATXN1[82Q] mice. Here we show that pharmacologic inhibition of S776 phosphorylation in transfected cells and SCA1 patient iPSC-derived neuronal cells lead to a decrease in ATXN1. In vivo, reduction of PKA-mediated ATXN1-pS776 results in enhanced degradation of ATXN1 and improved cerebellar-dependent motor performance. These results provide evidence that PKA is a biologically important kinase for ATXN1-pS776 in cerebellar Purkinje cells.

SUBMITTER: Perez Ortiz JM 

PROVIDER: S-EPMC6028938 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-05-31 | GSE114815 | GEO
2009-01-01 | S-EPMC2754139 | BioStudies
2018-01-01 | S-EPMC6422678 | BioStudies
1000-01-01 | S-EPMC3186404 | BioStudies
2016-01-01 | S-EPMC4795980 | BioStudies
2018-01-01 | S-EPMC6077814 | BioStudies
2018-01-01 | S-EPMC5983343 | BioStudies
2019-01-01 | S-EPMC6814966 | BioStudies
2018-01-01 | S-EPMC6348256 | BioStudies
2016-04-25 | GSE75778 | GEO